Search - tctmd.com

Displaying 301 - 320 of 2115

Sort: Relevancy | Date

Presentation TCT 2021

Rationale of Earlier AS Treatment: Asymptomatic Severe AS and Moderate AS

Presenter: Nicolas Van Mieghem

November 05, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

Presentation TCT 2021

Case #2: Antiplatelet Therapy Disruption Challenges After Stenting

Presenter: George Dangas

November 05, 2021

Presentation TCT 2021

TCT 602: Percutaneous Atrial Septal Defect Closure in an Adult With Ebstein Anomaly as a Palliative Therapy for Recurrent Stroke

Presenter: Alex Cubberley

November 05, 2021

Presentation TCT 2021

Routine Use Is Entirely Justifiable

Presenter: Axel Linke

November 05, 2021

Presentation TCT 2021

Chordal Repair Approaches (Harpoon, Pipeline, Chordart, Neochord, CardioMech)

Presenter: Anita Asgar

November 05, 2021

Presentation TCT 2021

TCT 601: Percutaneous Repair for Primary Triscuspid Regugitation With Flail TV Leaflet

Presenter: Amer Alaiti

November 05, 2021

Presentation TCT 2021

Not Indicated for Routine TAVR

Presenter: John K. Forrest

November 05, 2021

Presentation TCT 2021

Case #1: Bleeding and Ischemic Complications from the EXCEL Trial

Presenter: Gregg Stone

November 05, 2021

Presentation TCT 2021

Finding the Sweet Spot: Balancing Reducing Ischemic Risk and Reducing Bleeding Risk with Antiplatelet Therapy

Presenter: Deepak Bhatt

November 05, 2021

Presentation TCT 2021

Minimal Impact on Clinical Endpoints

Presenter: Hemal Gada

November 05, 2021

Presentation TCT 2021

TCT 613: A Unique Cause of Coronary Obstruction After Transcatheter Aortic Valve Replacement

Presenter: Chih-Wei Chang

November 05, 2021

Presentation TCT 2021

Leaflet Augmentation Technologies (Half-Moon, Polares, Dura-Sutra)

Presenter: Firas Zahr

November 05, 2021

Presentation TCT 2021

When to Shorten DAPT: Key Messages

Presenter: George Dangas

November 05, 2021

Presentation TCT 2021

Important Consideration for Valve Selection

Presenter: Tamim M. Nazif

November 05, 2021

Presentation TCT 2021

Annular Repair Strategies (Millipede, Carillon, Cardioband)

Presenter: Jason Rogers

November 05, 2021

Presentation TCT 2021

TCT 612: Unprotected Left Main Disease and TAVR: What Do We Do First?

Presenter: Ronald Rivas Gálvez

November 05, 2021

Presentation TCT 2021

Clinically Significant Phenomenon With Consequences

Presenter: Raj Makkar

November 05, 2021

Presentation TCT 2021

Antiplatelet Therapy for Patients with Diabetes Undergoing PCI

Presenter: Deepak Bhatt

November 05, 2021

Presentation TCT 2021

Limitations of TEER and Justification for Additional Transcatheter Repair Concepts

Presenter: Georg Nickenig

November 05, 2021

Advertisement

Rationale of Earlier AS Treatment: Asymptomatic Severe AS and Moderate AS

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Case #2: Antiplatelet Therapy Disruption Challenges After Stenting

TCT 602: Percutaneous Atrial Septal Defect Closure in an Adult With Ebstein Anomaly as a Palliative Therapy for Recurrent Stroke

Routine Use Is Entirely Justifiable

Chordal Repair Approaches (Harpoon, Pipeline, Chordart, Neochord, CardioMech)

TCT 601: Percutaneous Repair for Primary Triscuspid Regugitation With Flail TV Leaflet

Not Indicated for Routine TAVR

Case #1: Bleeding and Ischemic Complications from the EXCEL Trial

Finding the Sweet Spot: Balancing Reducing Ischemic Risk and Reducing Bleeding Risk with Antiplatelet Therapy

Minimal Impact on Clinical Endpoints

TCT 613: A Unique Cause of Coronary Obstruction After Transcatheter Aortic Valve Replacement

Leaflet Augmentation Technologies (Half-Moon, Polares, Dura-Sutra)

When to Shorten DAPT: Key Messages

Important Consideration for Valve Selection

Annular Repair Strategies (Millipede, Carillon, Cardioband)

TCT 612: Unprotected Left Main Disease and TAVR: What Do We Do First?

Clinically Significant Phenomenon With Consequences

Antiplatelet Therapy for Patients with Diabetes Undergoing PCI

Limitations of TEER and Justification for Additional Transcatheter Repair Concepts

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content